Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.85 is 65% above its 1-year average of 7.17, near the high end of its 1-year range (3.99–11.85).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.85.
CURRENT RATIO
11.85
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+218.17%
vs the sector median at left
Market Cap
$2.38B
Current Ratio
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$2.39B
Current Ratio
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
Market Cap
$2.44B
Current Ratio
2.08
TTM Avg
2.13
3Y Avg
1.75
5Y Avg
1.92
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.37B | 11.85 | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.38B | 5.03 | 4.66 | 4.92 | 7.11 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.39B | 1.50 | 1.54 | 1.54 | 1.56 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 6.97 | 6.34 | 6.18 | 6.55 |
| Disc Medicine, Inc. (IRON)vs › | $2.42B | 24.14 | 21.55 | 17.24 | 12.65 |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 3.00 | 2.62 | 2.45 | 2.80 |
| Liquidia Corporation (LQDA)vs › | $2.33B | 2.31 | 2.92 | 5.50 | 6.00 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.33B | 6.34 | 6.74 | 5.35 | 5.46 |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.44B | 2.08 | 2.13 | 1.75 | 1.92 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.30B | 4.05 | 7.06 | 7.46 | 6.71 |
Current Ratio
11.85
Quick Ratio
10.23
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.85 |
| 2026-03-31 | 5.68 |
| 2025-12-31 | 3.99 |
